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Abstract: Optimal and safe control of drug delivery systems with continuous infusion protocol
is of key importance to avoid over- or under-dosing of the patient. By implementing close-loops
one is able to optimize the amount of drug given to the patient. In this paper a robust control
methodology is presented. Emerging tools from fractional calculus have been considered and a
fractional order PI controller for drug dosing during hypnosis has been designed. In this paper a
robust fractional order control of hypnosis is proposed. The controller has been evaluated on an
artificial data set of 24 patients and the results indicate that such a control strategy is robust
to uncertainty stemming from the inter- and intra-patient variability.
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1. INTRODUCTION
Automatic drug delivery during anesthesia has been in-
vestigated for more than 50 years (Mayo et al., 1950).
However, despite the recent research and clinical trial
no real clinical breakthrough has been achieved. Closed-
loop control of anesthesia paradigm has been the focus of
several research groups. Pioneering work of Schwilden el al.
(Schwilden et al., 1989) used the median frequency of the
electroencephalogram (EEG) as an indication of depth of
hypnosis. In the 1990s Mahfouf and Linkens (Mahfouf and
Linkens, 1998) proposed a set of model based predictive
control methodologies for neuromuscular blockade control.
Then, in the late 1990s the development of BIS monitor
has reinforced the interest of researchers in closed-loop
control of hypnosis (Absalom et al., 2002; Liu et al., 2006;
Ionescu et al., 2008). Many of the studies were performed
in small clinical trials and in a well controlled environ-
ment, except Liu et al. (Liu et al., 2006) who reported
a system successfully tested in a multi-center study and
under routine clinical procedures.
Nowadays, in clinical practice the anesthesiologist man-
ually controls the amount of anesthetic drug given to
the patient. The commercially available delivery system
is the target controlled infusion (TCI) - open loop and
no feedback information from patient used. TCI systems
use population-based pharmacokinetic (PK) and pharma-
codynamic (PD) models to calculate an adequate infusion
profile to achieve the drug concentration defined by the
anesthesiologist, i.e. patient inter-variability is not taken
into account.
To tackle this challenging issue, closed loop control is a
good candidate having the potential to reduce the effect
of inter-patient variability and improve control of the
general anesthetic state (Bibian et al., 2005). To prove
this, feasibility studies have been performed in several
clinical trials in adults (Liu et al., 2006). Again, these
studies had a limited impact on clinical practice due to
due to concerns about the safety of these systems and the
reliability of the sensors. Even more, strong proofs that an
improvement in patient outcome is achieved are required
in order to convince the medical staff of the benefits of
closed loop control system for anesthesia. The large inter-
patient variability in individual responses to drug infusion
is an important cause for concern in the safety of closed-
loop systems.
Fully automated drug delivery systems for anesthesia
will be an important step forward in clinical practice. It
contributes to patient safety and reduces the workload of
the anesthesiologist while providing him more flexibility
to focus on critical issues. Moreover, a cost reduction
and a faster return of the patient to daily duties will
be achieved. There is significant research in the area
of individualized patient models and closed loop control
strategies for anesthesia (Ionescu et al., 2008; Padula et al.,
2016; Ionescu et al., 2014; Copot et al.).
In this paper a robust control methodology, i.e. fractional
order control, for hypnosis is presented. Tools from frac-
tional calculus will be employed towards an individualized
closed-loop control. In the last decades, the popularity of
the fractional order controllers has increased considerably,
with numerous applications in various fields, such as chem-
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Automatic drug delivery during anesthesia has been in-
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no real clinical breakthrough has been achieved. Closed-
loop control of anesthesia paradigm has been the focus of
several research groups. Pioneering work of Schwilden el al.
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control of hypnosis (Absalom et al., 2002; Liu et al., 2006;
Ionescu et al., 2008). any of the studies were performed
in small clinical trials and in a well controlled environ-
ment, except Liu et al. (Liu et al., 2006) who reported
a system successfully tested in a multi-center study and
under routine clinical procedures.
Nowadays, in clinical practice the anesthesiologist man-
ually controls the amount of anesthetic drug given to
the patient. The commercially available delivery system
is the target controlled infusion (TCI) - open loop and
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use population-based pharmacokinetic (PK) and pharma-
codynamic (PD) models to calculate an adequate infusion
profile to achieve the drug concentration defined by the
anesthesiologist, i.e. patient inter-variability is not taken
into account.
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control of hypnosis (Absalom et al., 2002; Liu et al., 2006;
Ionescu et al., 2008). Many of the studies were performed
in small clinical trials and in a well controlled environ-
ment, except Liu et al. (Liu et al., 2006) who reported
a system successfully tested in a multi-center study and
under routine clinical procedures.
Nowadays, in clinical practice the anesthesiologist man-
ually controls the amount of anesthetic drug given to
the patient. The commercially available delivery system
is the target controlled infusion (TCI) - open loop and
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use population-based pharmacokinetic (PK) and pharma-
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patient variability in individual responses to drug infusion
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Fully automated drug delivery systems for anesthesia
will be an important step forward in clinical practice. It
contributes to patient safety and reduces the workload of
the anesthesiologist while providing him more flexibility
to focus on critical issues. Moreover, a cost reduction
and a faster return of the patient to daily duties will
be achieved. There is significant research in the area
of individualized patient models and closed loop control
strategies for anesthesia (Ionescu et al., 2008; Padula et al.,
2016; Ionescu et al., 2014; Copot et al.).
In this paper a robust control methodology, i.e. fractional
order control, for hypnosis is presented. Tools from frac-
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Fig. 1. Schematic representation of a three compartmental PK-PD model of the patient.
component, i.e. analgesia, remains challenging for control
purposes because no direct output measure is available.
The aim of this paper is to design a robust model based
controller for the first phase of anesthesia (i.e. induc-
tion phase). When inducing and maintaining anesthesia,
anesthesiologists select initial doses based on a variety of
considerations, they observe the results, and then make
adjustments based on several factors, at irregularly varying
intervals. In control engineering terminology, this consti-
tutes a closed loop control system, due to the feedback
present in the observations and interventions of the anes-
thesiologist. This closed-loop control system has a special
nature. First, it has a human controller in the loop, and
second, the control actions are intermittent and irregular
in time due to the human controller.
The purpose of computer-controlled closed-loop systems is
to formalize the process of observation and intervention as
to provide better and more accurate control. Such systems
use a near continuous signal of drug effect, calculate the
error between the observed value and the setpoint value
(selected by the user), and use this error in an algorithm
to make frequent and regular adjustments to drug admin-
istration rates. Moreover, some computer-control systems
try to predict the future drug effect so that better adjust-
ments will be done in advance.
Numerous PID controllers have been designed during
decades, but because these controllers cannot anticipate
the response of the patient (Padula et al., 2016). Therefore,
model based control strategies have been developed. In
order to develop a satisfactory closed-loop drug delivery
system we need a number of elementary components. In
figure 2 a schematic of a feedback control strategy from
drug delivery point of view in anesthesia is presented.
The control system consists of four parts (Figure 2):
1) the patient as the system to be controlled;
2) the response, which is considered as a measurable rep-
resentation of the process to be controlled;
3) a model of the input-output relationship
4) a controller.
To achieve adequate anesthesia anesthesiologists regularly
adjust the settings of several drug infusion devices as well
as the parameters of the breathing system to modify the
manipulated variables. Several authors have recognized
the advantages associated with the use of automatic con-
trollers in anesthesia (Ionescu et al., 2008; Absalom et al.,
2011; Dumont, 2014) and they are briefly reviewed below.
First, if the routine tasks are taken over by automatic
controllers, anesthesiologists are able to concentrate on
critical issues which may threaten the patient’s safety.
Second, by exploiting both accurate infusion devices and
newly developed monitoring techniques, automatic con-
trollers would be able to provide drug administration pro-
files which may avoid over-dosing and under-dosing. The
ultimate advantage would be a reduction in costs due to
the reduced drug consumption and the shorter time spent
by the patient in the post anesthesia care unit.
Third, if enhanced with adaptation possibilities, initial
versions of automated depth of anesthesia regulation sys-
tems could provide individualized protocols if PD models
were to be adjusted to the actual patient instead of a
population based generic model parameters.
Finally, if tuned properly, automatic controllers may be
able to compensate and tailor the drug administration
profile to the particular stimulation intensity of each
surgical procedure (Dumont, 2014; Ionescu et al., 2008;
Absalom et al., 2011; Ionescu et al., 2015).
Fig. 2. Block diagram of a model-based adaptive closed-
loop system for automatic drug delivery.
In this paper we explore the powerfulness of fractional
calculus by means of a fractional order controller for anes-
thesia. Tools from fractional calculus have been employed
Proceedings of the 20th IFAC World Congress
Toulouse, France, July 9-14, 2017
15664
ical process control, magnetic levitation, etc (Muresan
et al., 2015, 2016b) Compared to the integer order con-
trollers, the fractional order ones offer increased flexibility
and can honor more closed loop performance constraints
simultaneously (Monje et al., 2010). For this reason, in
this paper, a fractional order PI controller is employed to
verify if added value exist.
The paper is structured as follows: In Section 2 the
pharmacokinetic-pharmacodynamic models used in mod-
eling of anesthesia paradigm are presented. In Section 3
the current state of the art of control of anesthesia is
given. In Section 4 the proposed control strategy followed
by discussion of the obtained results are presented. The
main outcome of this work is summarized in Section 5.
2. PATIENT MODEL
In automatic regulation of anesthesia, it is common prac-
tice to consider Propofol as input and Bispectral Index
(BIS) as output variables. BIS is a signal derived from the
electro-encephalogram (EEG) and is used in clinical prac-
tice to asses the level of consciousness during anesthesia.
BIS is defined between 0 (fully sedated) and 100 (fully
awake). In general in clinical practice the desired value
for BIS is between 40-60 range. The target value during
surgery is 50, therefore a range between 40-60 will ensure
that we have an adequate level of sedation.
Pharmacokinetic-pharmacodynamic (PK-PD) models are
used widely used in anesthesia since they represent the
basis of TCI systems. TCI systems are open loop devices,
i.e. drug infusion rate is adjusted manually by the anesthe-
siologist in order to achieve a target plasma concentration,
hence, no feedback is available. Despite these disadvan-
tages TCI has become very popular in clinical settings
(except North America) due to its ease of use. For Propofol
infusion several PK-PD models have been proposed and
studies have been performed in order to see the influence
of patient biometric parameters on the model parameters
(Schnider et al., 1999).
During general anesthesia the patient receives a hypnotic
drug (eg. Propofol) to ensure loss of consciousness and
absence of post-operative recall of events occurred dur-
ing surgery. Additionally, the patient receives a dose of
opioid drug (eg Remifentanil) to ensure the absence of
pain. Some reasons why Remifentanil is increasingly used
in combination with Propofol in todays clinical practice
are listed below: i) recently released sophisticated drug
delivery systems such as target-controlled infusion allow
for precise titration and safe administration in patients
with very narrow therapeutic margin; ii) some new clinical
applications are currently growing, such as Remifentanil’s
use as the sole agent for sedation during painful procedures
in patients breathing spontaneously, or as the analgesic
component in intensive care sedation; iii) simultaneously,
Remifentanil has permitted important scientific research,
leading to better understanding of postoperative hyperal-
gesia and acute tolerance to the analgesic action of opioids.
The overall effect of the drug infused in the human body
can be then modelled by considering the linear dynamics
of its pharmacokinetics and pharmacodynamics in series
with a static nonlinear function (Ionescu et al., 2008).
Most commonly used PK-PD model is the three compart-
ments model schematically depicted in Figure 1.
q˙1(t) = k21q2(t)+k31q3(t)−k12q1(t)−K01q1(t)+U(t) (1)
q˙2(t) = k12q1(t)− k21q2(t) (2)
q˙3(t) = k13q1(t)− k31q2(t) (3)
q˙e(t) = k1eq1(t)− k0eqe(t) (4)
In this Figure k12, k21, k13, k31, k1e represent the inter-
compartmental rate constants, k10 represents the clearance
rate from central compartment. Concentrations in each
compartment are denoted by C1 = q1/V1 - first compart-
ment, C2 = q2/V2 - second compartment, C3 = q3/V3 -
third compartment, Ce - effect site compartment, with V1,
V2 and V3 the corresponding compartment volume.
Then, the relation between plasma drug concentration Ce
and clinical effect can be mathematically expressed by
the means of a nonlinear sigmoid function, known also
as Hill function, which models the bispectral index scale
(BIS), a dimensionless parameter normalized between 0
and 100, indicating isoline EEG and fully awake patient
respectively:
BIS(t) = E0 − Emax Ce(t)
γ
Ce(t)γ + C
γ
e50
(5)
where E0 is the baseline value representing the initial
infusion-free state of the patient, Emax is the maximum
reachable effect achieved by the infusion, denotes the slope
of the curve (i.e., the receptiveness of the patient to the
drug) and Ce50 is the necessary concentration of the drug
to reach the half maximal effect. It is worth stressing that
the Hill function is highly non- linear. In fact, at the
beginning of the infusion, the curve presents a plateau,
where the presence of little quantities of the drug in the
effect compartment does not affect the clinical effect until
the drug concentration reaches a certain value. The final
saturation expresses the impossibility to overcome the
maximum achievable value Emax regardless of the amount
of hypnotic infused.
To conclude, even if PK-PD model became more and more
complex, Hill model remains the fundamental analytical
expression for these models (Csajka and Verotta, 2006).
The reasons why this model is used in PK-PD modeling
are: (1) can predict the maximum drug effect, which is a
key aspect of biological phenomena and (2) the flexibility
of the model in fitting data, this is due to the shape
parameter γ (known also as the coefficient of sigmoidicity).
3. CONTROL IN ANESTHESIA
Monitoring and controlling the depth of anesthesia for
surgical patients poses interesting challenges to the control
engineer (Haddad et al., 2011; Ionescu et al., 2016; Copot
and Ionescu, 2014) as it is a multi-variable interaction pro-
cess that has long captured the attention of engineers and
clinicians. From the three main areas of general anesthesia
(i.e. hypnosis, analgesia and neuromuscular blockade) hyp-
nosis (Dumont et al., 2009) and neuromuscular blockade
(Janda et al., 2011) are well characterized in terms of mod-
els, measured variables and closed loop control. The third
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Fig. 1. Schematic representation of a three compartmental PK-PD model of the patient.
component, i.e. analgesia, remains challenging for control
purposes because no direct output measure is available.
The aim of this paper is to design a robust model based
controller for the first phase of anesthesia (i.e. induc-
tion phase). When inducing and maintaining anesthesia,
anesthesiologists select initial doses based on a variety of
considerations, they observe the results, and then make
adjustments based on several factors, at irregularly varying
intervals. In control engineering terminology, this consti-
tutes a closed loop control system, due to the feedback
present in the observations and interventions of the anes-
thesiologist. This closed-loop control system has a special
nature. First, it has a human controller in the loop, and
second, the control actions are intermittent and irregular
in time due to the human controller.
The purpose of computer-controlled closed-loop systems is
to formalize the process of observation and intervention as
to provide better and more accurate control. Such systems
use a near continuous signal of drug effect, calculate the
error between the observed value and the setpoint value
(selected by the user), and use this error in an algorithm
to make frequent and regular adjustments to drug admin-
istration rates. Moreover, some computer-control systems
try to predict the future drug effect so that better adjust-
ments will be done in advance.
Numerous PID controllers have been designed during
decades, but because these controllers cannot anticipate
the response of the patient (Padula et al., 2016). Therefore,
model based control strategies have been developed. In
order to develop a satisfactory closed-loop drug delivery
system we need a number of elementary components. In
figure 2 a schematic of a feedback control strategy from
drug delivery point of view in anesthesia is presented.
The control system consists of four parts (Figure 2):
1) the patient as the system to be controlled;
2) the response, which is considered as a measurable rep-
resentation of the process to be controlled;
3) a model of the input-output relationship
4) a controller.
To achieve adequate anesthesia anesthesiologists regularly
adjust the settings of several drug infusion devices as well
as the parameters of the breathing system to modify the
manipulated variables. Several authors have recognized
the advantages associated with the use of automatic con-
trollers in anesthesia (Ionescu et al., 2008; Absalom et al.,
2011; Dumont, 2014) and they are briefly reviewed below.
First, if the routine tasks are taken over by automatic
controllers, anesthesiologists are able to concentrate on
critical issues which may threaten the patient’s safety.
Second, by exploiting both accurate infusion devices and
newly developed monitoring techniques, automatic con-
trollers would be able to provide drug administration pro-
files which may avoid over-dosing and under-dosing. The
ultimate advantage would be a reduction in costs due to
the reduced drug consumption and the shorter time spent
by the patient in the post anesthesia care unit.
Third, if enhanced with adaptation possibilities, initial
versions of automated depth of anesthesia regulation sys-
tems could provide individualized protocols if PD models
were to be adjusted to the actual patient instead of a
population based generic model parameters.
Finally, if tuned properly, automatic controllers may be
able to compensate and tailor the drug administration
profile to the particular stimulation intensity of each
surgical procedure (Dumont, 2014; Ionescu et al., 2008;
Absalom et al., 2011; Ionescu et al., 2015).
Fig. 2. Block diagram of a model-based adaptive closed-
loop system for automatic drug delivery.
In this paper we explore the powerfulness of fractional
calculus by means of a fractional order controller for anes-
thesia. Tools from fractional calculus have been employed
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Patient Age Hight Weight C50 γ
1 74 164 88 6.33 3.5
2 67 161 69 6.76 2.51
3 69 176 101 8.44 2.3
4 45 173 97 6.44 3.1
5 57 171 64 4.93 2.25
6 74 182 80 12.10 4.29
7 71 155 55 8.02 4.1
8 75 172 78 6.56 2.18
9 65 176 77 6.15 2.46
10 72 192 73 13.70 2.10
11 69 168 84 4.82 4.12
12 60 190 92 4.95 6.89
13 61 177 81 6.5 1.65
14 54 173 86 5.7 1.85
15 71 172 83 4.3 1.84
16 53 186 114 5.5 3
17 72 162 87 6.3 3
18 61 182 93 6.8 2.9
19 70 167 77 9.8 2.24
20 69 168 82 6.2 2.48
21 69 158 81 5.1 4.2
22 60 165 85 7.67 4.6
23 70 173 69 5.8 3.5
24 56 186 99 5.5 2.51
Table 1. Biometric parameters of the patients
used to calculate the PK-PD model parame-
ters.
In this paper the first phase of anesthesia, i.e. induction
phase is being considered. The induction of the patient
during general anesthesia is required to be done as fast
as possible, such that little time is lost before surgery can
start. Hence, it is desirable that the patient reaches the
BIS = 50% target and remains within the target value
without much undershoot (i.e. values below 30% should
be avoided). Therefore, the aim of the control strategy
proposed in this paper si to reach the setpoint in less
than 240 second. To achieve this goal a fractional order
controller has been designed an simulations have been
performed for a total of 24 patients.
In Figure 4 the Bode diagram of the open loop system,
considering the nominal model, as well as ±30% gain
variations, is given. The frequency response shows that the
performance specifications are met, with a gain crossover
frequency of 0.04 rad/s and a phase margin of 90 degrees.
The iso-damping property is also met, since the phase of
the open loop system around the gain crossover frequency
remains flat, indicating that a similar overshoot will be
obtained for the closed loop system, despite gain modelling
uncertainties.
The fractional order controller presented in section 4 has
been applied to the patient dataset presented in table
1. In Figure 5 the results of the closed loop simulations
for the controlled output (BIS) using the fractional order
controller are shown. In this phase, BIS is brought to its
reference value (i.e. 50%). From these results a significant
variability in the patient sensitivity to drug can be noticed.
This means that the C50 concentration varies highly from
patient to patient.
Fig. 4. Bode diagram of the open loop system for the
nominal patient.
Fig. 5. Closed loop response of BIS signal and Propofol
rate for all patients using FOPI control strategy.
6. CONCLUSIONS
The application of a closed-loop control strategies to drug
delivery will assist physicians in avoiding excessive over-
and under-dosages, optimizing the delivery of anesthet-
ics. Ideally, a robust controller would then tackle over-
and under-dosing by compensating for nonlinear drug re-
sponses, varying time delay, as well as inter- and intra-
patient variation.
In this paper a new model based control strategy has been
proposed for automatic drug dosage control during anes-
thesia. The proposed fractional order PI control scheme
was evaluated on a clinically derived dataset of patients
and a nominal patient. The designed control strategy
show good performance in dealing with some of the chal-
lenges of anesthesia, the nonlinearity and the inter- and
intra-patient variability. Moreover, the proposed control
methodology is able to induce the desired BIS reference
without any overshoot.
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in modeling PK-PD models but there were no attempt to
design a fractional order controller for anesthesia.
4. PROPOSED FRACTIONAL ORDER PI-CONTROL
STRATEGY
The tuning of a robust fractional order PI controller
(FOPI) is based on achieving three performance specifi-
cations that refer to a specific gain crossover frequency
ωcg and phase margin φm of the open loop system, as
well as the iso-damping property (Muresan et al., 2016a;
Petras, 2012) The transfer function of the fractional order
PI controller is:
HFO−PI(s) = kp
(
1 +
ki
sµ
)
(6)
where kp and ki are the proportional and the integral
gains, respectively, while µ ∈ (0,2) is the fractional order
of integration. The frequency domain representation of (6)
is obtained as:
HFO−PI(jω) = kp
[
1+kiω
−µ
(
cos
(
piµ
2
)
−j sin
(
piµ
2
))]
(7)
The design of the fractional order PI controller, according
to the three performance specifications, is based on solving
the following system of nonlinear equations:

(
Hopen−loop(jωcg)
)
= −pi + φm (8)
|(Hopen−loop(jωcg)) = 1 (9)
|(Hopen−loop(jωcg))
dω
∣∣∣∣
ω=ωcg
= 0 (10)
Assuming that the mathematical model of a nominal
patient is defined using a transfer function G(s), then the
equations (8)-(10) can be further described as:
∣∣∣∣kp[1 + kiω−µcg ( cos piµ2 − j sin piµ2
)]
=
1
|G(jωcg)| (11)
kiω
−µ
cg sin(
piµ
2 )
1 + kiω
−µ
cg cos(
piµ
2 ))
= tg(−pi + φm −  G(jωcg)) (12)
µkiω
−µ−1
cg sin(
piµ
2 )
1 + 2kiω
−µ
cg cos(
piµ
2 ) + k
2
i ω
−2µ
cg
=
d(  G(jω))
dω
∣∣∣∣
ω=ωcg
(13)
Equations (12) and (13) can then be used to determine
the controller parameters ki and µ based on a graphical
approach (Monje et al., 2010; Muresan et al., 2013). The
integral gain is computed based on (12) as a function of
the fractional order ki1 = f(µ). A similar approach is
considered for equation (13), resulting in ki2 = g(µ). The
two functions f and g are then plotted, the intersection
point between the two curves yielding the final values for
ki and µ. The proportional gain kp can be determined
afterwards using the modulus condition in (11).
To tune the fractional order PI controller, the nominal
patient model is considered to have the following transfer
function:
G(s) =
0.459(s+ 0.07165)
(s+ 0.6767)(s+ 0.459)(s+ 0.04653)
(14)
The performance specifications are imposed as a) a gain
crossover frequency ωcg = 0.04 rad/s, for a settling time
below 200 seconds, b) the phase margin φm = 90
o, for no
overshoot, and c) the iso-damping property. The graphical
solution for equations (12) and (13) is given in Figure
3, with the intersection point yielding ki = 0.192 and
µ = 0.935. Based on the modulus condition in (11), the
proportional gain kp = 0.124. The transfer function of the
fractional order PD controller is then:
HFO−PI(s) = 0.124
(
1 +
0.192
s0.935
)
(15)
An approximation method described is used to obtain the
continuous-time rational transfer function that approxi-
mates the fractional order PI controller in (15), within the
frequency range ω ∈ (10−3, 103) and N=6 (De Keyser and
Muresan, 2016; Monje et al., 2010).
Fig. 3. Graphical solution for fractional order PI controller
parameters: ki and µ.
5. RESULTS AND DISCUSSION
The most challenging part for anesthesia control is the
inter and intra-patient variability. In this paper we have
addressed this problem by fractional order control strat-
egy. The FO controller has been applied to a set of 24
patients presented in Table 1 in order to analyze the inter-
and intra-patient variability. A nominal patient is defined
using the mean of the biometric values presented in Table
1. There are many factor influencing the dose required
to induce anesthesia such as age, lean body mass, degree
of anxiety, infusion rate and co-administration of drugs
(Schnider et al., 1999).
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Patient Age Hight Weight C50 γ
1 74 164 88 6.33 3.5
2 67 161 69 6.76 2.51
3 69 176 101 8.44 2.3
4 45 173 97 6.44 3.1
5 57 171 64 4.93 2.25
6 74 182 80 12.10 4.29
7 71 155 55 8.02 4.1
8 75 172 78 6.56 2.18
9 65 176 77 6.15 2.46
10 72 192 73 13.70 2.10
11 69 168 84 4.82 4.12
12 60 190 92 4.95 6.89
13 61 177 81 6.5 1.65
14 54 173 86 5.7 1.85
15 71 172 83 4.3 1.84
16 53 186 114 5.5 3
17 72 162 87 6.3 3
18 61 182 93 6.8 2.9
19 70 167 77 9.8 2.24
20 69 168 82 6.2 2.48
21 69 158 81 5.1 4.2
22 60 165 85 7.67 4.6
23 70 173 69 5.8 3.5
24 56 186 99 5.5 2.51
Table 1. Biometric parameters of the patients
used to calculate the PK-PD model parame-
ters.
In this paper the first phase of anesthesia, i.e. induction
phase is being considered. The induction of the patient
during general anesthesia is required to be done as fast
as possible, such that little time is lost before surgery can
start. Hence, it is desirable that the patient reaches the
BIS = 50% target and remains within the target value
without much undershoot (i.e. values below 30% should
be avoided). Therefore, the aim of the control strategy
proposed in this paper si to reach the setpoint in less
than 240 second. To achieve this goal a fractional order
controller has been designed an simulations have been
performed for a total of 24 patients.
In Figure 4 the Bode diagram of the open loop system,
considering the nominal model, as well as ±30% gain
variations, is given. The frequency response shows that the
performance specifications are met, with a gain crossover
frequency of 0.04 rad/s and a phase margin of 90 degrees.
The iso-damping property is also met, since the phase of
the open loop system around the gain crossover frequency
remains flat, indicating that a similar overshoot will be
obtained for the closed loop system, despite gain modelling
uncertainties.
The fractional order controller presented in section 4 has
been applied to the patient dataset presented in table
1. In Figure 5 the results of the closed loop simulations
for the controlled output (BIS) using the fractional order
controller are shown. In this phase, BIS is brought to its
reference value (i.e. 50%). From these results a significant
variability in the patient sensitivity to drug can be noticed.
This means that the C50 concentration varies highly from
patient to patient.
Fig. 4. Bode diagram of the open loop system for the
nominal patient.
Fig. 5. Closed loop response of BIS signal and Propofol
rate for all patients using FOPI control strategy.
6. CONCLUSIONS
The application of a closed-loop control strategies to drug
delivery will assist physicians in avoiding excessive over-
and under-dosages, optimizing the delivery of anesthet-
ics. Ideally, a robust controller would then tackle over-
and under-dosing by compensating for nonlinear drug re-
sponses, varying time delay, as well as inter- and intra-
patient variation.
In this paper a new model based control strategy has been
proposed for automatic drug dosage control during anes-
thesia. The proposed fractional order PI control scheme
was evaluated on a clinically derived dataset of patients
and a nominal patient. The designed control strategy
show good performance in dealing with some of the chal-
lenges of anesthesia, the nonlinearity and the inter- and
intra-patient variability. Moreover, the proposed control
methodology is able to induce the desired BIS reference
without any overshoot.
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